The changing impact of cytomegalovirus among hematopoietic cell transplant recipients during the past decade: A single institutional cohort study.
Joyce J JohnsrudIsabelle T NguyenWalter DomingoAmit D RavalYuexin TangBalasubramanian NarasimhanBradley EfronJanice Wes BrownPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2022)
Preemptive therapy does not negate the impact of CMV-CSI on peri-engraftment toxicity and healthcare utilization. This cohort represents a large single center study on the impact of CMV in the preletermovir era and serves as a real-world comparator for assessing the impact of future prophylaxis.